| abstract |
The invention provides a compound comprising a mitochondrial targeting moiety, a charge moiety comprising a drug moiety, and a linker conjugating the mitochondrial targeting moiety and the charging moiety, wherein the mitochondrial cleavable linker moiety of a cell is intended to preferentially release the charge portion within the mitochondria by comparison with a cellular cytoplasm. |